AKASA

📍 South San Francisco, United States🗓 Founded 2019👥 222 employees💰 Last funded Jun 2022
Software Development🌐 akasa.com
Website LinkedIn
AKASA is rapidly becoming the GenAI partner of choice for leading health systems, with recent national recognition of our Cleveland Clinic deployment as “one of the most comprehensive real-world uses of GenAI in healthcare finance to date.” Across customers, AKASA now delivers an average of $3.1M in additional revenue and 4,270 additional quality indicators per 10,000 discharges, demonstrating consistent, measurable impact. Our advantage comes from building a custom LLM for each health system, capturing their clinical nuance to drive superior accuracy across the mid-cycle — spanning prior authorization, CDI, inpatient coding, and clinical denials appeals. This approach allows organizations to modernize critical workflows and unlock material improvements in both revenue and quality. With investors including Andreessen Horowitz, BOND, Costanoa Ventures, and others, we’ve raised more than $200M to help eliminate the financial complexity of healthcare. We’re rebuilding the revenue cycle with AI. Let’s chat.
4
Total investors
0
Early stage
4
Mid stage
0
Late stage
2019
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
United Kingdom
1
Frequently asked questions
Who invested in AKASA?
AKASA has 4 investors on record on gritt.io, 4 mid-stage.
When did AKASA last raise funding?
The most recent investment in AKASA recorded on gritt.io was in June 2022.
When was AKASA founded?
AKASA was founded in 2019.
What industry is AKASA in?
AKASA operates in Software Development. Find similar Software Development investors on gritt.io.
Where is AKASA based?
AKASA is headquartered in South San Francisco, United States.